Search
Sponsored By
AbbVie
Please Click On The Above Banner For More Details
Braintumor Website

Search Term: gleevec

There are no trials with that keyword - try a variation of it!

Brain Tumor News Articles About gleevec

  1. [03/07/2015] IBTA e-News From our friends at the IBTA 

  2. [02/10/2015] Could There Be a Gleevec for Brain Cancer?  Sounds very exciting. The protien is a  FGFR-TACC fusions in IDH wild type glioma

  3. [02/06/2013] Imatinib Reverses Doxorubicin Resistance by Affecting Activation of STAT3-Dependent NF-?B and HSP27/p38/AKT Pathways and by Inhibiting ABCB1.  I love this type of project. They are trying to find why the tumor becomes resistent to treatment and how to prevent that resistence.  They are using approved drugs - so if this can be shown to work in people, it can be used immediately by anyone and make a big impact.  

  4. [08/10/2012] The NovoTTF™-100A System selected as an award finalist based on its innovative design and 1st FDA approved indication for use against recurrent glioblastoma

  5. [12/04/2010] New Drugs Target Recurrent Meningioma

  6. [04/09/2009] Novartis’s Afinitor Pill May Be ‘Mega-Blockbuster’

  7. [03/30/2008] Potentiation of cytotoxicity by combination of imatinib and chlorimipramine in glioma.

  8. [09/15/2007] Targeted drug combos could outsmart cancer

  9. [06/04/2006] New Drug Holds Promise for Type of Breast Cancer  (Editor`s Note: Mentions Brain Mets)

  10. [05/09/2006]  M. D. Anderson: Setting the Benchmark in Brain Tumor Treatment

  11. [04/05/2006] A new approach to treating cancer

  12. [09/21/2005] Combination of Gleevec® and Hydrea® Offers Promise for Glioblastoma Multiforme

  13. [08/05/2004] Five brain cancers linked to single gene

  14. [07/04/2004] Medicare to Extend Access to Certain Drugs for Beneficiaries with Serious and Chronic Illnesses [Editor`s Note: includes Temodar!]

  15. [06/08/2004] Imatinib (STI 571) is active in patients (PTS) with high-grade gliomas progressing on standard therapy.

  16. [06/08/2004] Combined administration of imatinib mesylate and ionizing radiation leads to increased radiosensitivity in the human glioblastoma cell line RuSi RS1.

  17. [04/28/2004] Iressa news backgrounder: Testing of smart drug expands at M. D. Anderson Cancer Center

  18. [05/27/2003] Novartis Says Glivec Data May Support Wider Use

  19. [05/23/2003] Drug-Resistant Cancer Outwitted by Chemical Flank Attack

  20. [03/01/2003] Distribution of STI-571 to the Brain Is Limited by P-Glycoprotein-Mediated Efflux.

  21. [12/31/2002] Patterns - The Future of Cancer Research

  22. [07/04/2002] Bug Puts Sting in Cancer Fight

  23. [02/28/2002] Gleevec Holds Up in Long-Term Study (HealthSCOUT)
    ... the FDA also approved Gleevec for treating gastrointestinal stromal tumors (GIST), a rare form of solid cancer that affect about 5,000 Americans a year.......These range from tumors in the brain and bone to those in the skin and eyes....
    - Feb 27 11:54 PM ET


  24. [12/18/2001] `01 Had Breakthrough in Angioplasty (AP)
    ... a new drug effective against an unusual digestive cancer called gastrointestinal stromal tumors.......It is also being tested in lung, prostate and brain cancer. Standard chemotherapy goes after all fast-dividing cells and kills them indiscriminately....
    - Dec 17 2:21 PM ET


  25. [06/26/2001] Novartis details Glivec findings, sticks to outlook (Reuters Securities)
    ... effectively turns off the relatively rare, but fatal cancer,...... to treat solid tumours that appear in cancer of the brain,...... Glivec would probably be more successful in treating cancers other than CML or GIST if used in combination with...
    - Jun 26 10:30 AM ET


  26. [06/25/2001] Dr. Bruce A. Chabner, Editor-In-Chief of ~~~The Oncologist~~~ Journal, States: ~~~STI571 (Gleevec) Represents a Monumental Leap Forward In Cancer Chemotherapy ... the Oncologic Equivalent of Breaking the Four-Minute Mile.~~~ (PR Newswire)
    ... myelogenous leukemia and in gastrointestinal stromal tumors (GIST)....... underway in prostate cancer, lung cancer, gliomas (brain tumors),...
    - Jun 25 1:50 PM ET


  27. [05/13/2001] New Cancer Drugs Disappointing (Associated Press)
    ...None of the drugs prompted the kind of dramatic tumor shrinkage or disappearance that doctors look for even in the first stages of human testing,......pioneered the field called angiogenesis, which involves trying to starve tumors with chemicals that stop them from building new blood vessels.......The drug is also being tested in lung, prostate and brain cancer.-...
    - May 13 5:23 PM ET


  28. [05/13/2001] New Data Suggest Novartis Drug Gleevec(TM) (Formerly STI571) Effective In Rare Form of Gastrointestinal Tumor (PR Newswire)
    Novartis Oncology today announced that data on the activity of Gleevec(TM) in a rare form of gastrointestinal stromal tumor will be highlighted during the key plenary session of the 37th annual meeting of the American Society for Clinical Oncology in San Francisco, California.
    - May 13 12:00 PM ET


  29. [05/11/2001] Breakthrough Cancer Drug Lifts Novartis Shares (Reuters)
    ...Attention now turns to initial trial results due on Monday that may give clues about how well the innovative leukemia drug can handle solid cancerous tumors as well.......Novartis says it also inhibits two other proteins: the c-kit receptor linked to GIST and small cell lung cancers, and the PDG-F receptor, active in some kinds of brain, prostate and soft tissue cancer....
    - May 11 7:21 AM ET


  30. [05/08/2001] Leukemia & Lymphoma Society(SM) to Provide Information on Gleevec(TM) (PR Newswire)
    ...WHAT: With expedited regulatory review of Gleevec(TM) (STI-571), the oral investigational agent from Novartis Oncology,...
    - May 08 6:06 PM ET


  31. [05/10/2001] The Leukemia & Lymphoma Society(SM) Enters Into Education Partnership With Novartis (PR Newswire)
    The Leukemia & Lymphoma Society is pleased to join in a collaborative partnership with Novartis to educate the public about Gleevec(TM), Novartis` new oral medication approved by the U.S.
    - May 10 1:52 PM ET


  32. [05/10/2001] U.S. FDA approves Novartis cancer drug Gleevec (Reuters Securities)
    U.S. health officials said on Thursday they approved Novartis AG`s oral cancer treatment Gleevec for fighting a rare life-threatening type of leukemia.
    - May 10 1:32 PM ET


  33. [05/10/2001] FDA Approves Novartis Cancer Drug Gleevec (Reuters)
    U.S. Health and Human Services Secretary Tommy Thompson announced on Thursday government approval for Novartis AG`s (NOVZn.S) (NVS.N) oral cancer treatment Gleevec for fighting a rare life-threatening type of leukemia.
    - May 10 2:10 PM ET


  34. [05/10/2001] ADVISORY/FDA Approves Novartis` Unique Leukemia Medication Gleevec (Business Wire)
    ...Novartis today announced that the United States Food and Drug Administration (FDA) approved its drug Gleevec(tm) (imatinib mesylate) as an oral therapy for the treatment of patients with chronic myeloid leukemia (CML) in the blast crisis,...
    - May 10 3:31 PM ET


  35. [05/10/2001] FDA Approves Novartis Cancer Drug (Forbes.com)
    Regulators pass Gleevec, a promising leukemia drug, after three months of review. A Forbes.com Special Report.
    - May 10 4:44 PM ET


  36. [05/10/2001] FDA Approves Novartis` Unique Leukemia Medication Gleevec(TM)* (imatinib mesylate) (PR Newswire)
    Novartis today announced that the United States Food and Drug Administration approved its drug Gleevec(TM) as an oral therapy for the treatment of patients with chronic myeloid leukemia in the blast crisis, accelerated phase or in chronic phase after failure of interferon-alpha therapy.
    - May 10 3:34 PM ET


  37. [05/10/2001] Government Approves Novartis Cancer Drug Gleevec (Reuters)
    ... - U.S. officials on Thursday announced approval in record time for a breakthrough oral cancer drug that has shown dramatic results against a rare but deadly type of leukemia.U.S. Health and Human Services Secretary Tommy Thompson announced government approval for Novartis AG`s oral drug Gleevec for fighting chronic myeloid leukemia, a disease that causes a deadly overproduction of white blood cells....
    - May 10 4:07 PM ET


  38. [05/10/2001] U.S. Approves Novartis Cancer Drug Gleevec (Reuters)
    ... - U.S. officials on Thursday announced approval in record time for a breakthrough oral cancer drug that has shown dramatic results against a rare but deadly type of leukemia.U.S. Health and Human Services Secretary Tommy Thompson announced government approval for Novartis AG`s oral drug Gleevec for fighting chronic myeloid leukemia, a disease that causes a deadly overproduction of white blood cells....
    - May 10 4:09 PM ET


  39. [05/10/2001] U.S. approves Novartis cancer drug Gleevec (Reuters Securities)
    ...U.S. Health and Human Services Secretary Tommy Thompson announced government approval for Novartis AG`s oral drug Gleevec for fighting chronic myeloid leukemia, a disease that causes a deadly overproduction of white blood cells....
    - May 10 3:59 PM ET






Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740